Hadassah

Press Release: Hadassah Names Joshua W. Rednik as Chief Development Officer

Thursday, Mar 22 2018

MEDIA INQUIRIES:
Contact: Renee Young
Hadassah National Public Relations
ryoung@hadassah.org
212.303.8140

Hadassah Names Joshua W. Rednik as Chief Development Officer


Joshua W. Rednik
Chief Development Officer
March 21, 2018 – NEW YORK, NY – Joshua W. Rednik, CFP®, has been named Chief Development Officer for Hadassah, the Women’s Zionist Organization of America, Inc, (HWZOA) announced Janice Weinman, Hadassah Executive Director/CEO.  Rednik will supervise the planning, execution and implementation of all of Hadassah’s fundraising initiatives and campaigns in support of its programs and advocacy efforts in the United States and the Hadassah Medical Organization (HMO) including its two world-class hospitals in Jerusalem.  

Rednik, who brings to Hadassah more than twenty years of experience in the non-profit sector, managing organizations and developing and executing multi-million-dollar fundraising campaigns, will spearhead Hadassah’s recently-announced $91.2M Full Circle Capital Campaign which will renovate and expand HMO’s historic Round Building at the Ein Kerem campus. 

Weinman states, “In this year of many Hadassah centennial milestones – the 100th anniversaries of HMO, the Henrietta Szold Hadassah-Hebrew University School of Nursing and HMO’s Department of Ophthalmology – Joshua brings a wealth of exciting new fundraising ideas and strategies to further our mission of supporting HMO’s outstanding medical care for the people of Israel and the world.  His successful record as President / CEO of the Diabetes Research Institute Foundation (DRIF) and his contacts in the Jewish community will be important assets for Hadassah’s fundraising strategies.” 

Rednik states, “Hadassah has a long and venerable history of support and service to the land and people of Israel and a distinguished record of achievement in the US in advocacy for issues important to women. I am eager to contribute my fundraising skills on behalf of this outstanding organization.” 

During Rednik’s tenure as President and CEO of the Diabetes Research Institute Foundation (DRIF) from 2014-2018, he and his team raised over $60M from foundations, corporations and individuals in support of DRIF’s mission to cure type 1 diabetes.

Prior to DRIF, Rednik served as Executive Director of the Jewish Community Foundation (JCF) of Greater MetroWest in Whippany, NJ from 2008-2013.  During his tenure, Rednik and his team created and implemented JCF’s $100M “MetroWest Tomorrow” Endowment Campaign, exceeding its original goal ahead of schedule.

Rednik has also held senior leadership roles within the major gifts and planning giving and endowment divisions of UJA-Federation of New York and the Jewish Federation of Greater Washington (Rockville, MD). 

Rednik is a graduate of Washington University in St. Louis with a BA in Psychology and received his MSS in Social Service at Bryn Mawr College, Bryn Mawr, PA.  A Certified Financial Planner™ professional, he received an Executive Certificate in Financial Planning from Georgetown University in Washington, DC.  He resides in South Orange, NJ with his wife and two children.  

Hadassah, the Women’s Zionist Organization of America, Inc. (HWZOA) is the largest Jewish women’s organization in the United States. With 330,000 members, associates and supporters Hadassah brings Jewish women together to effect change and advocate on critical issues such as medical care and research and women's empowerment.  Through the Hadassah Medical Organization's two hospitals, the world-renowned trauma center and the leading research facility in Jerusalem, Hadassah supports the delivery of exemplary patient care to over a million people every year. HMO serves without regard to race, religion or nationality and earned a Nobel Peace Prize nomination in 2005 for building “bridges to peace” through equality in medical treatment. For more information, visit www.hadassah.org.

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Tuesday, Apr 17 2018

Where are we with Stem Cells? Hadassah Pioneer Brings Us Up to Date

Many diseases involve the malfunctioning or dying of cells within the body.

READ MORE ›
alt_text

Tuesday, Apr 17 2018

Predicting Clinical Outcomes for Multiple Sclerosis Patients: Cutting-Edge Research at Hadassah

More than two million people--two to three times more women--have multiple sclerosis (MS)--the leading cause of neurological disability among young adults. What is their prognosis?

READ MORE ›
alt_text

Friday, Apr 13 2018

Hadassah Hospital Mount Scopus Hosts Conference to Mark Annual World Down Syndrome Day

Hadassah Hospital Mount Scopus hosted 200 people at the annual World Down Syndrome Day conference, held at the hospital in late March.

READ MORE ›
alt_text

Friday, Apr 13 2018

Hadassah Physicians Increase Number of Partial Thyroidectomies Following New ATA Guidelines

Following updated recommendations from the American Thyroid Association (ATA), Nir Hirschoren, M.D., of the Hadassah-Hebrew University Medical Center in Jerusalem...

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More